Mark G. Foletta, Director at DEXCOM INC (DXCM), sold 1,927 shares at $226.20 ($439K) on 2019-12-03, disclosed to the SEC on 2019-12-05.
Open-market sale of $439k DXCM by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $221.34 | 3 | $664 | 0.2% |
| 2 | $223.41 | 70 | $16K | 3.6% |
| 3 | $226.20 | 232 | $52K | 12.0% |
| 4 | $226.20 | 232 | $52K | 12.0% |
| 5 | $227.66 | 233 | $53K | 12.1% |
| 6 | $227.66 | 233 |
| $53K |
| 12.1% |
| 7 | $228.93 | 462 | $106K | 24.1% |
| 8 | $228.93 | 462 | $106K | 24.1% |
| Total | $227.75 avg | 1,927 | $439K | 100% |
| Filing → |
| DXCM | SELL | 2026-06-17 | $297K | — | Filing → |
| DXCM | SELL | 2025-08-18 | $430K | — | Filing → |
| DXCM | SELL | 2025-07-17 | $468K | — | Filing → |